Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01657578Phase 2Completed
A Phase 2 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01657578.